Albert David Limited
Albert David Limited is an Indian listed company in the Pharmaceuticals & Biotechnology industry (Healthcare sector), traded under NSE: ALBERTDAVD and BSE: 524075 (ISIN INE155C01010).
It has a market capitalisation of ₹455 crore, a last close of ₹797.75 on 2026-10-19, a one-year return of 0.7%.
Valuation: a price-to-earnings ratio of 20.18x, a price-to-book ratio of 1.16x, a dividend yield of 0.6%.
Profitability: return on equity of -0.4%, return on capital employed of 0.8%, an operating margin of 7.3%.
Growth: sales growth of -0.8% a year over three years.
Balance sheet and ownership: debt-to-equity of 0.07x, promoter holding of 62.2%.
| Metric | Value |
|---|---|
| Market capitalisation | 455 |
| Last close | ₹797.75 |
| P/E (TTM) | 20.18x |
| P/B | 1.16x |
| Dividend yield | 0.6% |
| ROE (FY) | -0.4% |
| ROCE (FY) | 0.8% |
| Operating margin (TTM) | 7.3% |
| Sales growth, 3-year CAGR | -0.8% |
| Debt / equity | 0.07x |
| Promoter holding | 62.2% |
| 1-year return | 0.7% |
Loading the live page with the price chart, financial history, shareholding and recent filings. Data is end-of-day and rebuilt nightly; nothing here is investment advice. Financial statements · What each metric means